Sarah Hayes, SSPC, John Halligan TD, Dr Ann Ledwith, Dean of Graduate & Professional Studies at UL and Jon O’Halloran, SSPC at the launch at the university Picture: Oisin McHugh/True Media
A NEW Specialist Diploma has been launched at the University of Limerick aimed at graduates with a background in the pharmaceutical or quality and manufacturing sectors.
The new course, in Regulatory Affairs in (Bio) Pharmaceuticals, is a joint endeavour between the Synthesis and Solid State Pharmaceutical Research Centre (SSPC), Science Foundation Ireland (SFI) Research Centre and UL.
Intended for Irish-based regulatory professionals, it emerged from a strong industry demand in recent years for regulatory affairs (RA) professionals in Ireland for the pharmaceutical industry.
“Regulatory Affairs is critical to the future success of such a highly regulated industry and building academic links with industry ensures graduates can tailor their education to meet the demands of the emerging market,” said Minister of State for Training, Skills, Innovation and Research, John Halligan TD, at the launch.
The healthcare products landscape has evolved substantially in the past few decades, and today there are new emerging technologies and an improved understanding of patient and consumer needs. Regulatory professionals who can successfully navigate this new professional landscape are in high demand and short supply, say the SSPC.
Dr Sarah Hayes, SSPC, said that the programme “addresses a gap in the training of regulatory affairs personnel”.
“The programme is designed to offer a unique opportunity in Ireland to gain a level 9 accredited Specialist Diploma in Regulatory Affairs and EU requirements,” she added.
Commenting on the announcement, Dr Ann Ledwith, Dean of Graduate and Professional Studies at UL, said: “The University of Limerick has a strong track record of delivering programmes to meet industry needs. Fees for the Specialist Diploma are funded through Springboard, it is a great opportunity for RA professionals to upskill as they work.”